NEW YORK, Oct 20 (Reuters) - Fred Hassan, the chief executive of Schering-Plough Corp. (SGP.N: Quote, Profile, Research), on Friday said he has high hopes an experimental company drug to prevent blood clots will be launched in 2010 or 2011 and become a big seller.>>> Discuss This Story
